Publications by authors named "Jonathan Webster"

Claim this Profile
R
Recognition, prevention, and management of adverse events associated with asparaginase/ pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel.
Emily Curran, Marlise R Luskin, Houda Alachkar, Ibrahim Aldoss, Patrick W Burke, Jonathan Webster

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free DNA screening results by stage of maternal malignancy.
Emily Zhao, Kristen A Miller, Jonathan Webster, Jamie Perin, Ashley Coggins

Am J Obstet Gynecol MFM· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing care for older people with learning disabilities in the emergency department.
James Rushton, Jonathan Webster, Anca Manea, Gail Meers, Victoria Dawson

Nurs Older People· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy.
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, Philip H Imus, Douglas B Smith

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML.
Andrew D Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A Webster, Mark J Levis, Ivana Gojo

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities.
J Preston Claiborne, Daniel Li, Hua-Ling Tsai, Gabriel Ghiaur, B Douglas Smith, Jonathan A Webster

Leuk Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.
Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova, Yasmin Abaza, Theodoros Karantanos, Jonathan Webster

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss, Jonathan Webster

J Natl Compr Canc Netw· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol.
Neil D Palmisiano, Ju-Whei Lee, David F Claxton, Elisabeth M Paietta, Hassan Alkhateeb, Jonathan A Webster

EJHaem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing critical enquiry, capacity, capability and confidence in the health and care workforce.
Claire L Whitehouse, Jonathan Webster, Jacky Copping, Paul Morris, Jonathan Yazbek

Br J Nurs· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the sustainable impacts of a clinical healthcare research scholarship programme.
Claire L Whitehouse, Helen Hall, Mehar Shiju, Jonathan Webster, Jonathan Yazbek

Br J Nurs· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.
Sabine Kayser, Chiara Sartor, Fabio Giglio, Alessandro Bruno, Jonathan Webster

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death.
Jia Jia, Wenbo Ji, Antoine N Saliba, Clifford M Csizmar, Kaiqin Ye, Jonathan A Webster

Cell Death Differ· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome heterogeneity of -mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation.
Sergiu Pasca, Saurav D Haldar, Alexander Ambinder, Jonathan A Webster, Tania Jain

Haematologica· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia.
Aref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, Carrie A Strand, Bijal Shah, Jonathan Webster

Cancer Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methyltransferase inhibitor exposure-response: Challenges and opportunities.
Amanda B Kagan, Dominique A Garrison, Nicole M Anders, Jonathan A Webster, Sharyn D Baker

Clin Transl Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
This CAR won't start: predicting nonresponse in ALL.
Jonathan A Webster, Leo Luznik

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of an atypical BCR::ABL1 fusion in a patient with secondary B-cell acute lymphoblastic leukemia/lymphoma following multiple myeloma treatment.
Karin Miller, Jonathan Webster, Philip Imus, Candice Ament, Melanie Hardy

Cancer Genet· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease.
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, Matthew Newman, Jonathan A Webster

Leuk Lymphoma· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, Alexander Ambinder, Tania Jain

Transplant Cell Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Widespread Erosions in Intertriginous Areas.
Alejandra Méndez, Jonathan Webster, Sahand Rahnama-Moghadam

Cutis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embedding research (ER) led by nurses, midwives and allied health professionals (NMAHPs): the NMAHP-ER model.
Claire Louise Whitehouse, Linda Tinkler, Carolyn Jackson, Helen Hall, Jonathan Webster

BMJ Lead· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: A thematic analysis of system wide learning from first wave Covid-19 in the east of England.
Carolyn Jackson, Kim Manley, Jonathan Webster, Sally Hardy

BMC Health Serv Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use.
Akshan Puar, Diane Donegan, Paul Helft, Matthew Kuhar, Jonathan Webster

AACE Clin Case Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoster paresis in a renal transplant patient: preliminary considerations.
Erica L Aukerman, Sara Garcia-Dehbozorgi, Jonathan Webster, Sahand Rahnama-Moghadam

BMJ Case Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis